Comprehensive assessment of inflammatory status in RA typically incorporates composite clinical measures (such as DAS28, SDAI, CDAI), patient-reported outcomes (e.g., VAS pain/global assessment), and serological markers (e.g., RF, ACPA) alongside CRP/ESR. Here, PRTN3 is linked to rheumatoid arthritis.